Empagliflozin
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients (NCT05147090) | The University of Hong Kong | 2022-01-02 |
| Antidiabetic Drugs for Steatotic Liver Disease (NCT03646292) | Yonsei University | 2018-12-06 |
Track Empagliflozin automatically
Every clearance here is in the API, with alerts when new ones post.